Literature DB >> 10101379

Research on needle exchange: redefining the agenda.

J A Hantman1.   

Abstract

Researchers studying needle-exchange programs in the United States pursue a two-fold agenda that requires answers to these questions: (1) Do such programs successfully reduce HIV seroprevalence among injecting drug users? (2) Do they promote drug use? Several federal laws and regulations require convincing data on each question before the release of federal funds for needle exchange. Fears that needle exchange promotes drug use are at the core of federal concerns, and these fears are shared by community leaders, scientists, and public health professionals. Nonetheless, the manner in which the "drug use" question has been framed and addressed in scientific research has been given insufficient attention. This article aims to stimulate debate about current research, and restore a focus on HIV prevention, by addressing several methodological, logical, and ethical weaknesses that characterize the scientific inquiry into whether needle exchange promotes drug use.

Entities:  

Mesh:

Year:  1995        PMID: 10101379      PMCID: PMC2359432     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


  13 in total

1.  When science and politics collide: the federal response to needle-exchange programs.

Authors:  P Lurie
Journal:  Bull N Y Acad Med       Date:  1995

2.  Meaning and context: the social facts of intravenous drug use and HIV transmission in the inner city.

Authors:  J K Watters
Journal:  J Psychoactive Drugs       Date:  1988 Apr-Jun

3.  The sharing of drug injection equipment and the AIDS epidemic in New York City: the first decade.

Authors:  D C Des Jarlais; S R Friedman; J L Sotheran; R Stoneburner
Journal:  NIDA Res Monogr       Date:  1988

4.  HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.

Authors:  D C Des Jarlais; S R Friedman; D M Novick; J L Sotheran; P Thomas; S R Yancovitz; D Mildvan; J Weber; M J Kreek; R Maslansky
Journal:  JAMA       Date:  1989-02-17       Impact factor: 56.272

Review 5.  Relapse prevention: an emerging technology for promoting long-term drug abstinence.

Authors:  W DeJong
Journal:  Int J Addict       Date:  1994-04

6.  Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.

Authors:  D C Des Jarlais; S R Friedman; W Hopkins
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

7.  Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers--Connecticut, 1992-1993.

Authors:  S L Groseclose; B Weinstein; T S Jones; L A Valleroy; L J Fehrs; W J Kassler
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-09-01

8.  Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users.

Authors:  C A Latkin; D Vlahov; J C Anthony
Journal:  Addiction       Date:  1993-04       Impact factor: 6.526

9.  Understanding AIDS: historical interpretations and the limits of biomedical individualism.

Authors:  E Fee; N Krieger
Journal:  Am J Public Health       Date:  1993-10       Impact factor: 9.308

10.  Syringe and needle exchange as HIV/AIDS prevention for injection drug users.

Authors:  J K Watters; M J Estilo; G L Clark; J Lorvick
Journal:  JAMA       Date:  1994-01-12       Impact factor: 56.272

View more
  1 in total

1.  Addiction treatment: promoting a medical approach to substance use.

Authors:  G L Stein; A R Fleischman
Journal:  J Urban Health       Date:  1998-09       Impact factor: 3.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.